Market Value326,955,000
Total Holdings72
File Date2020-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MRNA / Moderna, Inc. Put
DGX / Quest Diagnostics Incorporated
GMED / Globus Medical, Inc.
UHS / Universal Health Services, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
HUM / Humana Inc.
PODD / Insulet Corporation
NTRA / Natera, Inc.
AMGN / Amgen Inc.
GWP / GW Pharmaceuticals plc
ACHC / Acadia Healthcare Company, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
PNTG / The Pennant Group, Inc.
CTLT / Catalent, Inc.
MRK / Merck & Co., Inc.
BHC / Bausch Health Companies Inc.
ALEC / Alector, Inc.
US3723091043 / GenMark Diagnostics, Inc
GMXAY / Genmab A/S
US60877T1007 / Momenta Pharmaceuticals, Inc.
ZGNX / Zogenix Inc
NUVA / Nuvasive Inc
INO / Inovio Pharmaceuticals, Inc. Put
EHTH / eHealth, Inc.
DRNA / Dicerna Pharmaceuticals Inc
CHNG / Change Healthcare Inc
CHWY / Chewy, Inc.
AGIO / Agios Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
DNLI / Denali Therapeutics Inc.
EXEL / Exelixis, Inc.
HALO / Halozyme Therapeutics, Inc.
GH / Guardant Health, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
ITCI / Intra-Cellular Therapies, Inc.
MCRB / Seres Therapeutics, Inc.
LHCG / LHC Group Inc
KNSA / Kiniksa Pharmaceuticals, Ltd.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
AKBA / Akebia Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
KPTI / Karyopharm Therapeutics Inc.
ARNA / Arena Pharmaceuticals Inc
SGEN / Seagen Inc
NBIX / Neurocrine Biosciences, Inc.
KURA / Kura Oncology, Inc.
EW / Edwards Lifesciences Corporation
CCXI / ChemoCentryx Inc
INCY / Incyte Corporation
ABT / Abbott Laboratories
INSM / Insmed Incorporated
ALNY / Alnylam Pharmaceuticals, Inc.
CNC / Centene Corporation
GOSS / Gossamer Bio, Inc.
GOSS / Gossamer Bio, Inc. Call
RVTY / Revvity, Inc.
MYOV / Myovant Sciences Ltd
DTIL / Precision BioSciences, Inc.
SWAV / Shockwave Medical, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc. Call
COR / Cencora, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
NVST / Envista Holdings Corporation
IRTC / iRhythm Technologies, Inc.
DHR / Danaher Corporation
MOH / Molina Healthcare, Inc.
BPMC / Blueprint Medicines Corporation
BMY / Bristol-Myers Squibb Company
PTCT / PTC Therapeutics, Inc.
BAX / Baxter International Inc.
BMRN / BioMarin Pharmaceutical Inc.
RETA / Reata Pharmaceuticals Inc - Class A
NVRO / Nevro Corp.
CRL / Charles River Laboratories International, Inc.
SAGE / Sage Therapeutics, Inc.
MGNX / MacroGenics, Inc.
FATE / Fate Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
ABBV / AbbVie Inc.
DXCM / DexCom, Inc.
GKOS / Glaukos Corporation
HOLX / Hologic, Inc.
CYTK / Cytokinetics, Incorporated
WBA / Walgreens Boots Alliance, Inc.
LLY / Eli Lilly and Company
MCK / McKesson Corporation
CYTK / Cytokinetics, Incorporated Call
APLS / Apellis Pharmaceuticals, Inc.
EXAS / Exact Sciences Corporation